Skip to main content
. 2013 Sep 19;2013:313142. doi: 10.1155/2013/313142

Table 2.

Subjects details.

Treatment Number of subjects completing the study Age Compliance Tolerability Dropouts
150 mg + best management 37 (14 females) 51.33; 5.31 94% Very good 0
300 mg + best management 35 (18 females) 49.9; 5.2 95% Very good 0
Best management 47 (19 females) 49.4; 3 95% Very good 3